Cargando…
Efficient simulation of clinical target response surfaces
Simulation of combination therapies is challenging due to computational complexity. Either a simple model is used to simulate the response for many combinations of concentration to generate a response surface but parameter variability and uncertainty are neglected and the concentrations are constant...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007598/ https://www.ncbi.nlm.nih.gov/pubmed/35199969 http://dx.doi.org/10.1002/psp4.12779 |
_version_ | 1784686883536633856 |
---|---|
author | Lill, Daniel Kümmel, Anne Mitov, Venelin Kaschek, Daniel Gobeau, Nathalie Schmidt, Henning Timmer, Jens |
author_facet | Lill, Daniel Kümmel, Anne Mitov, Venelin Kaschek, Daniel Gobeau, Nathalie Schmidt, Henning Timmer, Jens |
author_sort | Lill, Daniel |
collection | PubMed |
description | Simulation of combination therapies is challenging due to computational complexity. Either a simple model is used to simulate the response for many combinations of concentration to generate a response surface but parameter variability and uncertainty are neglected and the concentrations are constant—the link to the doses to be administered is difficult to make—or a population pharmacokinetic/pharmacodynamic model is used to predict the response to combination therapy in a clinical trial taking into account the time‐varying concentration profile, interindividual variability (IIV), and parameter uncertainty but simulations are limited to only a few selected doses. We devised new algorithms to efficiently search for the combination doses that achieve a predefined efficacy target while taking into account the IIV and parameter uncertainty. The result of this method is a response surface of confidence levels, indicating for all dose combinations the likelihood of reaching the specified efficacy target. We highlight the importance to simulate across a population rather than focus on an individual. Finally, we provide examples of potential applications, such as informing experimental design. |
format | Online Article Text |
id | pubmed-9007598 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90075982022-04-15 Efficient simulation of clinical target response surfaces Lill, Daniel Kümmel, Anne Mitov, Venelin Kaschek, Daniel Gobeau, Nathalie Schmidt, Henning Timmer, Jens CPT Pharmacometrics Syst Pharmacol Research Simulation of combination therapies is challenging due to computational complexity. Either a simple model is used to simulate the response for many combinations of concentration to generate a response surface but parameter variability and uncertainty are neglected and the concentrations are constant—the link to the doses to be administered is difficult to make—or a population pharmacokinetic/pharmacodynamic model is used to predict the response to combination therapy in a clinical trial taking into account the time‐varying concentration profile, interindividual variability (IIV), and parameter uncertainty but simulations are limited to only a few selected doses. We devised new algorithms to efficiently search for the combination doses that achieve a predefined efficacy target while taking into account the IIV and parameter uncertainty. The result of this method is a response surface of confidence levels, indicating for all dose combinations the likelihood of reaching the specified efficacy target. We highlight the importance to simulate across a population rather than focus on an individual. Finally, we provide examples of potential applications, such as informing experimental design. John Wiley and Sons Inc. 2022-03-11 2022-04 /pmc/articles/PMC9007598/ /pubmed/35199969 http://dx.doi.org/10.1002/psp4.12779 Text en © 2022 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of the American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Lill, Daniel Kümmel, Anne Mitov, Venelin Kaschek, Daniel Gobeau, Nathalie Schmidt, Henning Timmer, Jens Efficient simulation of clinical target response surfaces |
title | Efficient simulation of clinical target response surfaces |
title_full | Efficient simulation of clinical target response surfaces |
title_fullStr | Efficient simulation of clinical target response surfaces |
title_full_unstemmed | Efficient simulation of clinical target response surfaces |
title_short | Efficient simulation of clinical target response surfaces |
title_sort | efficient simulation of clinical target response surfaces |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007598/ https://www.ncbi.nlm.nih.gov/pubmed/35199969 http://dx.doi.org/10.1002/psp4.12779 |
work_keys_str_mv | AT lilldaniel efficientsimulationofclinicaltargetresponsesurfaces AT kummelanne efficientsimulationofclinicaltargetresponsesurfaces AT mitovvenelin efficientsimulationofclinicaltargetresponsesurfaces AT kaschekdaniel efficientsimulationofclinicaltargetresponsesurfaces AT gobeaunathalie efficientsimulationofclinicaltargetresponsesurfaces AT schmidthenning efficientsimulationofclinicaltargetresponsesurfaces AT timmerjens efficientsimulationofclinicaltargetresponsesurfaces |